CTOs on the Move


 
Health for health. This describes Zilis. We are building the world`s finest health and wellness brand. Our expert team` headed by Derrick DeSilva` M.D.` brings the latest science to our Ambassadors and customers. We are also founded on the belief that all children deserve adequate nutrition. With every sale` we provide life saving nutrition to children in developing countries.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.zilis.com
  • 415 US Highway 377 Street 2020
    Argyle, TX USA 76226
  • Phone: 214.705.3702

Executives

Name Title Contact Details

Similar Companies

Starr Regional Medical Center

Starr Regional Medical Center will be your trusted source online not only for your hospital information, but also for the time-saving, easy to use, in-depth healthcare information resource you`ll want to refer to frequently. Be active in your healthcare decisions, not a spectator. That`s why we give you access to millions of pages of the most credible, up-to-date medical information available. You can rely on such expert sources as The Merriam Webster Medical Dictionary.

Arbour Group

Arbour Group is a Oakbrook Terrace, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lutronic USA

Lutronic USA is a Princeton Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Thermotex Therapy Systems

Thermotex Therapy Systems Ltd. is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fractyl Laboratories

At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.